HOUSTON – (Realty News Report) – Hines has leased 30,000 SF of life sciences space in Levit Green, the 53-acre mixed-use life sciences-centric district adjacent to the Texas Medical Center in Houston.
Plus Therapeutics, Inc., Celltex Therapeutics, and Oxia Therapeutics are moving into Levit Green, which is located near the intersection of Holcombe Boulevard and Highway 288.
Completed in 2023, Levit Green’s first phase is a lab, biomanufacturing facility designed with flexibility in mind to meet the evolving needs of the life sciences industry. The 290,000-SF, five-story building is part of the broader nine-building Levit Green master plan, which will offer a curated mix of research and production facilities, office, retail, residential, and outdoor amenities.
The life sciences district is being developed on land formerly occupied by The Grocers Supply Co. Hines is developing Levit Green in partnership with 2ML Real Estate Interests and Harrison Street.
“This accelerated leasing activity reflects the demand for high-quality, flexible lab space in Houston’s life sciences ecosystem,” said John Mooz, senior managing director at Hines. “Levit Green is uniquely positioned to support companies at every stage with immediate occupancy options and custom-built suites, all within a collaborative, innovation-focused environment.”
The Three New Tenants at Levit Green
The new companies at Levit Green are Plus Therapeutics, Inc., Celltex Therapeutics, and Oxia Therapeutics.
Plus Therapeutics, Inc. (Nasdaq: PSTV) , a US-based healthcare company developing advanced pharmaceuticals, diagnostics, and data analytics technologies for central nervous system (CNS) cancers, has leased an 11,370-SF, turn-key lab and office space on the second floor of Levit Green’s Phase I building. Plus Therapeutics will occupy the space immediately for their wholly owned subsidiary, CNSide Diagnostics LLC, while a new, purpose-built laboratory and office is constructed on the third floor, tailored to their long-term operational needs.
“Plus Therapeutics’ fully integrated CNS healthcare platform strategically positions us to lead the charge in prolonging lives in patients with brain and CNS cancers,” said Marc H. Hedrick, M.D., Plus Therapeutics President and Chief Executive Officer. “Our new, best-in class facility at Levit Green, in the heart the world’s largest medical center, gives us the optimal footprint to execute commercially and maximizes our opportunities for collaboration, scientific advancement and clinical development.”
Celltex Therapeutics, a leading regenerative medicine company specializing in adult stem cell banking, GMP manufacturing, and advanced cellular therapies, will relocate its headquarters to Levit Green, leasing 13,800 SF to consolidate its administrative offices, biomanufacturing, and cellular banking operations. Celltex’s custom, purpose-built space includes the construction of a GMP cleanroom and laboratory space specifically designed to support the Company’s clinical, regulatory and operational requirements.
“As a leader in advanced regenerative medicine technologies, our strategic relocation to the life sciences district adjacent to the Texas Medical Center marks the beginning of a new era for Celltex,” said Anita Perry, Chairman and Chief Executive Officer of Celltex Therapeutics. “Since 2011, our mission has been to develop life-changing regenerative medicine technologies for all walks of life, and as the life sciences landscape continues to evolve, it is essential that we operate in an environment capable of advancing alongside it. Celltex’s relocation was diligently represented by Scott Visin, Managing Director, and Charles Dorfman, Senior Associate, and provides us with the world-class laboratory infrastructure needed to support our clinical development programs while also welcoming in the next generation of innovation.”
Oxia Therapeutics is pioneering a new class of medicine that reawakens the body’s innate repair systems to restore health at the cellular level, comprising a team of scientists and innovators dedicated to translating bold science into meaningful human impact. The biotech company has leased 5,460 SF for BSL-2 lab and office use.
More Spec Suites to be Built-Out by Hines
To meet growing demand for smaller footprint tenants, three additional suites of +/- 5,000 SF each of turnkey lab space with lab benching, casework, and furniture will be delivered by fall 2026, resulting in a total of 37,000 SF of spec lab space ready for leasing next year.
Completed in 2023, Levit Green’s first phase is a state-of-the-art lab, biomanufacturing facility designed with flexibility in mind to meet the evolving needs of the life sciences industry. The 290,000-SF five-story building is part of the broader nine-building Levit Green master plan, which will offer a curated mix of research & production facilities, office, retail, residential, and outdoor amenities.
Hines, founded in Houston in 1957 by Mr. Gerald D. Hines, has 4,600 employees in 30 countries around the globe.
Dec. 4, 2025 Realty News Report Copyright 2025
Images: Courtesy Hines
THE RALPH BIVINS PROJECT PODCAST
LISTEN: THE RALPH BIVINS PROJECT with David Hightower
LISTEN: THE RALPH BIVINS PROJECT with Alex Kamkar of Bold Fox Development
LISTEN: THE RALPH BIVINS PROJECT with Brad McWhirter of Trahan Architects
LISTEN: THE RALPH BIVINS PROJECT with Lacee Jacobs of Rebel Retail Advisors
LISTEN: THE RALPH BIVINS PROJECT with Danny Rice of Colliers
LISTEN: THE RALPH BIVINS PROJECT with Trey Odom of Avera
LISTEN: THE RALPH BIVINS PROJECT with Kris Larson of Downtown Houston +
LISTEN: THE RALPH BIVINS PROJECT with Jim Carman of Howard Hughes Holdings
LISTEN: THE RALPH BIVINS PROJECT with Sam Scott of CommGate
File: Hines Adds 3 Life-Science Tenants at Levit Green John Mooz, Harrison Street, Hines Adds 3 Life-Science Tenants at Levit Green